Loading
A group of oncologists in Guatemala City that has been a site for many international cancer drug trials, in breast, stomach and lung cancer among others.
Grupo Médico Ángeles is listed on ClinicalTrials.gov as a Guatemala City site of trials the corpus holds, including ALEX, APHINITY, CLEOPATRA, GATSBY, KATHERINE, IMpassion130, OAK, LIDERA and HERIZON-GEA-01. Its CRECE website names Hugo Castro, a medical oncologist trained at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico and an associate professor of the Guatemala National Cancer Institute, as medical director, with research interests in the natural history of breast cancer, and describes him as a co-investigator in multicentre trials in breast, lung and gastric cancer. The coordinates are an approximate Guatemala City point.
Shares A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies, APHINITY, KATHERINE.
Shares lidERA, A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies, CLEOPATRA.
Shares A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer), lidERA.
Shares GATSBY, A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies, KATHERINE.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/